-
BioMarin resigned to ending journey with hemophilia A gene therapy Roctavian, seeks divestiture amid sales struggle
28 Oct 2025 23:21 GMT
… could take for its struggling hemophilia A gene therapy, Roctavian. … play in the treatment of hemophilia A and are therefore … a variety of treatments for hemophilia A, including Roche’s blockbuster … to rid itself of the hemophilia A med, BioMarin remains …
-
BioMarin looks to divest hemophilia gene therapy Roctavian
28 Oct 2025 17:06 GMT
-
BioMarin, following sluggish sales, to offload hemophilia gene therapy
27 Oct 2025 23:49 GMT
… is giving up on the hemophilia gene therapy Roctavian, announcing … the chronic therapies people with hemophilia A use to prevent bleeding … therapy for the less common hemophilia B. Uptake has also … for CSL’s Hemgenix, another hemophilia B gene therapy.
Last …
-
UK MHRA grants marketing authorization to Novo Nordisk's concizumab to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors
27 Oct 2025 06:29 GMT
… years and older with haemophilia A or B with … (clotting factor VIII for haemophilia A and clotting factor IX … for haemophilia B).
The new marketing … prevent bleeding in people with haemophilia.?
Concizumab is injected subcutaneously …
-
Essential Screenings Every Woman Should Know About
29 Oct 2025 11:29 GMT
… sickle cell anemia, cystic fibrosis, hemophilia, and thalassemia.
Screening both partners …
-
Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More
29 Oct 2025 12:44 GMT
… announced plans to divest the hemophilia gene therapy Roctavian. Regeneron faced …
-
CM Maryam redefined public service in Punjab: Kh Imran Nazir
29 Oct 2025 09:26 GMT
… undergoing treatment for thalassemia and hemophilia. Upon arrival, Khawaja Imran Nazir …
-
Off-Label Prescribing Was Common, Novo Nordisk Tells Jury
29 Oct 2025 03:42 GMT
… Tuesday that she previously prescribed hemophilia drugs for off-label use …
-
Roc in hard place: Biomarin plans divestment to ratchet up numbers
28 Oct 2025 22:50 GMT
… its pioneering gene therapy for hemophilia, Roctavian (valoctocogene roxaparvovec), and remove …
-
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
28 Oct 2025 21:57 GMT
… products, Roctavian, which treats severe hemophilia A. It said this …